- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05012657
Validation of Point Partial User Needs With Partial Finger Amputees
December 28, 2023 updated by: Point Designs
The objective of the device feasibility study will be to validate the user needs of the Point Partial system.
This study will be a single group intervention model where one group of 5 partial finger amputees will be asked to perform several tasks.
Successful completion of a task results in a fulfilled user need.
Failure to complete a task results in an unfulfilled user need.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Levin Sliker, PhD
- Phone Number: 7206004753
- Email: levin@pointdesignsllc.com
Study Contact Backup
- Name: Richard Weir, PhD
- Phone Number: 8479121032
- Email: richard.weir@cuanschutz.edu
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado Denver | Anschutz Medical Campus
-
Lafayette, Colorado, United States, 80026
- Point Designs
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Partial finger amputees with partial absence of index and/or middle fingers and presence of thumb. Additional finger loss is acceptable if all other criterion are met.
- Fluent in English
- Individuals aged 18 or greater
- Patients may present with either fused or mobile MCP joints.
Exclusion Criteria:
- Significant cognitive deficits as determined upon clinical evaluation
- Significant neurological deficits as determined upon clinical evaluation
- Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation
- Uncontrolled pain or phantom pain impacting full participation in the study as determined upon OT evaluation
- Serious uncontrolled medical problems as judged by the project therapist.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Prosthesis
Patient is temporarily fit with Point Partial partial finger prosthetic system
|
The Point Partial partial finger prosthetic system consists of 1-4 ratcheting mechanical partial digits and mounting brackets
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
VAL-1
Time Frame: Day 1 (8 hours)
|
User wears Point Partial(s) for a full day (Pass/Fail)
|
Day 1 (8 hours)
|
VAL-2
Time Frame: Day 1 (10 minutes)
|
User flexes and extends the Point Partial(s) without using contralateral hand (Pass/Fail)
|
Day 1 (10 minutes)
|
VAL-3.1
Time Frame: Day 1 (10 minutes)
|
User lifts a 25 lb.
bag with Point Partial(s) (Pass/Fail)
|
Day 1 (10 minutes)
|
VAL-3.2
Time Frame: Day 1 (10 minutes)
|
User grips a hammer with Point Partial(s) and drives a nail into a piece of wood (Pass/Fail)
|
Day 1 (10 minutes)
|
VAL-4
Time Frame: Day 1 (10 minutes)
|
User releases Point Partial(s) while performing an active grasp by pressing the dorsal button (Pass/Fail)
|
Day 1 (10 minutes)
|
VAL-5
Time Frame: Day 1 (10 minutes)
|
User positions Point Partial(s) into each of the locking positions (Pass/Fail)
|
Day 1 (10 minutes)
|
VAL-6
Time Frame: Day 1 (10 minutes)
|
User activates spring-back mechanism by using (1) contralateral hand, (2) tabletop, and (3) side or thigh throughout day without failed extension (Pass/Fail)
|
Day 1 (10 minutes)
|
VAL-7
Time Frame: Day 1 (10 minutes)
|
User grips a 5 lb.
cylindrical smooth object using Point Partial(s) for 10 seconds (Pass/Fail)
|
Day 1 (10 minutes)
|
VAL-8
Time Frame: Day 1 (10 minutes)
|
User picks up 1 coin from a smooth tabletop (Pass/Fail)
|
Day 1 (10 minutes)
|
VAL-9
Time Frame: Day 1 (8 hours)
|
User performs VAL-1 through VAL-8 (Pass/Fail)
|
Day 1 (8 hours)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 3, 2020
Primary Completion (Actual)
December 31, 2022
Study Completion (Actual)
December 31, 2022
Study Registration Dates
First Submitted
August 12, 2021
First Submitted That Met QC Criteria
August 12, 2021
First Posted (Actual)
August 19, 2021
Study Record Updates
Last Update Posted (Estimated)
January 1, 2024
Last Update Submitted That Met QC Criteria
December 28, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 299089
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Amputation; Traumatic, Hand
-
Shirley Ryan AbilityLabEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingAmputation; Traumatic, Hand, and Wrist | Amputation; Traumatic, Hand, at Wrist LevelUnited States
-
Boninger, Michael, MDNational Institute of Neurological Disorders and Stroke (NINDS); Ripple Therapeutics...RecruitingAmputation | Amputation; Traumatic, HandUnited States
-
Centre hospitalier de l'Université de Montréal...RecruitingAmputation; Traumatic, HandCanada
-
Centre hospitalier de l'Université de Montréal...RecruitingAmputation; Traumatic, HandCanada
-
Point DesignsUniversity of Colorado, Denver; Arm DynamicsCompletedAmputation; Traumatic, HandUnited States
-
Point DesignsUniversity of Colorado, Denver; Arm DynamicsCompletedAmputation; Traumatic, HandUnited States
-
Point DesignsUniversity of Colorado, DenverCompletedAmputation; Traumatic, HandUnited States
-
University of Texas Southwestern Medical CenterUniversity of Minnesota; Arizona State University; Defense Advanced Research... and other collaboratorsRecruitingAmputation; Traumatic, HandUnited States
-
Liberating Technologies, Inc.Össur EhfCompletedAmputation | Prosthesis User | Amputation; Traumatic, Hand | Upper Limb Amputation at the Hand | Limb; Absence, Congenital, UpperUnited States
-
Martin BerliBern University of Applied SciencesCompletedAmputation; Traumatic, HandSwitzerland
Clinical Trials on Point Partial
-
Point DesignsUniversity of Colorado, Denver; Arm DynamicsCompletedAmputation; Traumatic, HandUnited States
-
University Health Network, TorontoWithdrawn
-
University Hospital, CaenRecruitingDeep Vein ThrombosisFrance
-
Marshall UniversityArthrex, Inc.; Medstar Washington Hospital CenterRecruitingMeniscus TearUnited States
-
Saint Petersburg State University, RussiaCompletedRenal Tumor | Renal Malignant TumorRussian Federation
-
Rabin Medical CenterUnknownTumor | Laparoscopy | NephrectomyIsrael
-
Hospital de Clinicas de Porto AlegreCompletedDeviated Nasal Septum | Nasal Septal Defect | Nasal Septum, IrregularBrazil
-
Zhongnan HospitalNot yet recruiting
-
Yale UniversityActive, not recruitingBreast CancerUnited States
-
Johns Hopkins UniversityTerminatedChemotherapy-induced Peripheral Neuropathy (CIPN)United States